New resource highlights costs and benefits of falls prevention interventions

New resource highlights costs and benefits of falls prevention interventions

February 19 2018 A new return on investment tool has been published bringing together evidence on...

FSRH issues statement contraception for women using known teratogenic drugs

FSRH issues statement contraception for women using known teratogenic drugs

February 16 2018 New guidance has been issued advising about contraceptive options for women...

PHE seeks feedback on usefulness of Smokefree Health Harms resources

PHE seeks feedback on usefulness of Smokefree Health Harms resources

February 15 2018 Public Health England is asking for health professionals to give feedback on...

Long-term opioid prescribing is increasing, finds BJGP study

Long-term opioid prescribing is increasing, finds BJGP study

February 14 2018 GPs have increased long-term opioid prescribing for non-cancer pain against...

'Stay Well Pharmacy' promotes community pharmacy to parents for children's minor ailments

'Stay Well Pharmacy' promotes community pharmacy to parents for children's minor ailments

February 12 2018 A new campaign is urging parents to consult a pharmacist first if their child...

  • New resource highlights costs and benefits of falls prevention interventions

    New resource highlights costs and benefits of falls prevention interventions

    Monday, 19 February 2018 11:06
  • FSRH issues statement contraception for women using known teratogenic drugs

    FSRH issues statement contraception for women using known teratogenic drugs

    Friday, 16 February 2018 18:12
  • PHE seeks feedback on usefulness of Smokefree Health Harms resources

    PHE seeks feedback on usefulness of Smokefree Health Harms resources

    Thursday, 15 February 2018 16:13
  • Long-term opioid prescribing is increasing, finds BJGP study

    Long-term opioid prescribing is increasing, finds BJGP study

    Wednesday, 14 February 2018 14:48
  • 'Stay Well Pharmacy' promotes community pharmacy to parents for children's minor ailments

    'Stay Well Pharmacy' promotes community pharmacy to parents for children's minor ailments

    Monday, 12 February 2018 14:37

a man taking medication imageFebruary 2 2018

Details of the review into prescribed medicines that may cause dependence or withdrawal have been set out.


Public Health Minister Steve Brine has commissioned Public Health England to review the evidence and report back in early 2019. It has been asked to look at:

  • prevalence and prescribing patterns;
  • the nature and likely causes of dependence or discontinuation syndrome among some people who take these medicines;
  • effective prevention and treatment of dependence and discontinuation syndrome for each drug category.

Drug classes specifically targeted will be benzodiazepines, Z-drugs, GABA-ergic medicines, opioid pain medications, antidepressants, as well as those that are prescribed to treat anxiety, insomnia, chronic non-cancer pain and depression. The review will look at the use of the medicines by adults, and community prescribing.

Not included in the review’s remit are:

  • cancer and terminal pain;
  • over-the-counter medicines;
  • prescribing in hospitals and prisons;
  • other medicines, such as anti-psychotics, stimulants, ‘smart drugs’, or anti-obesity drugs.

PHE will use a number of methods to gather evidence, including “analysing all prescription and some GP patient data to understand prevalence and detail of prescribing patterns, patients and conditions.”

Link:
PHE announcement      

Professional News

February 21 2018 Public Health Wales has published further information about the tendering process for GP software which has seen EMIS Health not able to continue as a supplier.
February 20 2018 New British Thoracic Society guidelines on pleural mesothelioma include some key recommendations for primary care. The BTS guideline give recommendations and good practice points...